---
category: news
title: "Revolutionary UK machine learning biotech firm agrees deal to develop new cancer treatments"
excerpt: "Etcembly, a revolutionary biotech company that uses machine learning to identify and predict the effectiveness of future immune therapies, has agreed a partnership with leading Norwegian firm Zelluna to engineer T-cell receptors (TCRs) from Zellunaâ€™s ..."
publishedDateTime: 2022-04-12T15:14:00Z
originalUrl: "https://www.pharmiweb.com/press-release/2022-04-12/revolutionary-uk-machine-learning-biotech-firm-agrees-deal-to-develop-new-cancer-treatments"
webUrl: "https://www.pharmiweb.com/press-release/2022-04-12/revolutionary-uk-machine-learning-biotech-firm-agrees-deal-to-develop-new-cancer-treatments"
type: article
quality: 29
heat: 29
published: false

provider:
  name: PharmiWeb
  domain: pharmiweb.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png"
    width: 1200
    height: 448
    isCached: true

secured: "8P9tYg/JnuAsvlUEUBWE++6uJj+yk/4wV/J3FgyoQvmJLBEyRkFfURlJ6uRay/tHBVgJnRFN3zSFUTxRLpkIywsPf1zkHRUIjN/KpZQuUEHbuQVLop+tDUYzjjM9y7Eo1yBtOF1V6sPfBBZpYdwoERDxU6v/0Lafr8fzaImB4h+TD11dI0tOwnThDMgaCP7no8tpDFE6hNM2f75lva0vcrqLIw2UlwR2Oc5LPQPsl/G0Z4rCwEH6/ITEUWfO1KSFvKuIfHhjn12DHtW5V2tN9SfYwxG9phrDdrHJ52If60BbCrsYshG9qT+06c77H66O7CJobm4pTjE1BGRs7XBnQBFjJHmf9dKhr500S2/seKM=;/nS5i82fXxM6aP2m7pbxwg=="
---

